Qatar vs Saint Vincent and the Grenadines: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Qatar
99.0%
in 2025
Saint Vincent and the Grenadines
99.0%
in 2025
Qatar rank
1st
Saint Vincent and the Grenadines rank
1st
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Qatar
- Saint Vincent and the Grenadines
How they compare
Qatar currently reports 99.0% against 99.0% in Saint Vincent and the Grenadines, a difference of 0.0%.
The two have swapped places 8 times across 26 shared years of data; in 2000 it was Saint Vincent and the Grenadines ahead.
Qatar ranks 1st and Saint Vincent and the Grenadines ranks 1st of 194 countries.
Across the 3 decades both report, Qatar averaged higher in 1 and Saint Vincent and the Grenadines in 2.
Head to head by decade
| Decade | Qatar | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 74.7% | 80.9% | 6.2% | Saint Vincent and the Grenadines |
| 2010s | 95.9% | 96.1% | 0.2% | Saint Vincent and the Grenadines |
| 2020s | 97.2% | 97.0% | 0.2% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Qatar or Saint Vincent and the Grenadines?
- Qatar, at 99.0% against 99.0% in Saint Vincent and the Grenadines as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Qatar and Saint Vincent and the Grenadines?
- 0.0%, with Qatar ahead.
- How many years of comparable data are there for Qatar and Saint Vincent and the Grenadines?
- 26 years are reported by both, from 2000 to 2025.
- How do Qatar and Saint Vincent and the Grenadines rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Qatar ranks 1st and Saint Vincent and the Grenadines ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.